Cargando…

Corrigendum: Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183719/ https://www.ncbi.nlm.nih.gov/pubmed/33883405 http://dx.doi.org/10.1097/CM9.0000000000001482

Ejemplares similares

Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study
por: Liu, Ru, et al.
Publicado: (2017)

Corrigendum to “Serial Changes of Neointimal Tissue after Everolimus-Eluting Stent Implantation in Porcine Coronary Artery: An Optical Coherence Tomography Analysis”
por: Won, Hoyoun, et al.
Publicado: (2019)

Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2019)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
por: Wang, Zhongxia, et al.
Publicado: (2019)

Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
Publicado: (2019)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
por: Ma, Yuan-Liang, et al.
Publicado: (2018)

Corrigendum to Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
Publicado: (2023)

Corrigendum to: Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
Publicado: (2019)

First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
por: Jeger, Raban, et al.
Publicado: (2016)

First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry)
por: Kawecki, Damian, et al.
Publicado: (2016)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Coronary artery perforation successfully treated with a second drug-eluting stent
por: Strycek, Matej, et al.
Publicado: (2023)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
por: Whitbeck, Matthew G., et al.
Publicado: (2013)

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?
por: Oh, Pyung Chun, et al.
Publicado: (2019)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Corrigendum to “Relationship between the Direction of Ophthalmic Artery Blood Flow and Ocular Microcirculation before and after Carotid Artery Stenting”
por: Ishii, Masashi, et al.
Publicado: (2017)

Corrigendum to “Clinical Outcomes and Rotational Correction of First Metatarso-Cuneiform Fusion With First Metatarsal to Second Cuneiform Fixation”
Publicado: (2023)

Corrigendum: A first step toward understanding patient safety
por: Kim, Kyoung Ok
Publicado: (2017)

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2013)

Second Generation Drug-Eluting Stents for Endovascular Treatment of Ostial Vertebral Artery Stenosis: A Single Center Experience
por: Ortega-Gutierrez, Santiago, et al.
Publicado: (2019)

Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry
por: de Souza, Cristiano Freitas, et al.
Publicado: (2013)

Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome
por: Jang, Ji-Yong, et al.
Publicado: (2018)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
por: Tang, Xiao-Fang, et al.
Publicado: (2018)

Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients
por: Choi, Seonghoon, et al.
Publicado: (2015)

Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents()
por: Kilickesmez, Kadriye, et al.
Publicado: (2014)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry
por: Ahn, Jong-Hwa, et al.
Publicado: (2016)

Five-year clinical outcomes of first-generation versus second-generation drug-eluting stents following coronary chronic total occlusion intervention
por: Kim, Yong Hoon, et al.
Publicado: (2019)

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents
por: Kim, Byeong-Keuk, et al.
Publicado: (2012)

Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis
por: Yan, Peng, et al.
Publicado: (2014)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
por: Liu, Yen-Wen, et al.
Publicado: (2021)

Validation of second trimester miscarriages and spontaneous deliveries [Corrigendum]
Publicado: (2017)

Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation Drug-Eluting Stents
por: Yoshikawa, Yusuke, et al.
Publicado: (2021)

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
por: Papadopoulos, Kyriacos, et al.
Publicado: (2017)

Corrigendum to: The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: results of the SYNTAX II study
Publicado: (2019)

Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease
por: Adnan, Yasir, et al.
Publicado: (2017)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fo452rrbt3qq8jk5e8dngr0uuv